Introduction to Regulatory Affairs 2020 (complete)
The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.
-
Day 1, Monday, September 28
-
8:30 - 9:00
-
Registration and coffee
-
-
9:00 - 9:15
-
Welcome & introduction to the course - Marc Benijts
-
-
9:15 - 10:15
-
Pharmaceuticals - definitions - product life cycle - Lieve Lammens (Janssen Research and Development)
-
-
10:15 - 11:15
-
The European Union and its institutions - The Belgian bodies - Peter Bogaert (Covington & Burling LLP) - Bart Van Vooren (Covington & Burling LLP)
-
-
11:15 - 11:45
-
Coffee break
-
-
11:45 - 12:45
-
The pharmaceutical legislation (EU - B) - Peter Bogaert (Covington & Burling LLP) - Bart Van Vooren (Covington & Burling LLP)
-
-
12:45 - 13:45
-
Lunch
-
-
13:45 - 14:45
-
European Medicines Agency - EU procedures for Marketing Authorisations - part 1 - Ingrid Theewes (PhaRA) & Frank Vandendriessche (PhaRA)
-
-
14:45 - 15:00
-
Coffee break
-
-
15:00 - 15:45
-
European Medicines Agency - EU procedures for Marketing Authorisations - part 2 - Ingrid Theewes (PhaRA) & Frank Vandendriessche (PhaRA)
-
-
15:45 - 17:00
-
Pharmacovigilance - Ellen Felix (Pfizer)
-
-
Day 2, Tuesday, September 29
-
9:00 - 10:15
-
Legislation for clinical trials - Benedikt Van Nieuwenhove (European Centre for Clinical Research - ECCRT)
-
-
10:15 - 10:45
-
Coffee break
-
-
10:45 - 11:45
-
CTD module 3 - Evelien Wynendaele (UGent)
-
-
11:45 - 12:45
-
CTD module 4 - Gaƫlle De Meyer (FAMHP)
-
-
12:45 - 13:45
-
Lunch
-
-
13:45 - 14:45
-
CTD module 5 - Nele Berthels (FAMHP)
-
-
14:45 - 16:00
-
Variations - renewals - extensions - Sarah Skouta (Merck Sharp & Dohme Europe)
-
-
16:00 - 16:15
-
Coffee break
-
-
16:15 - 17:15
-
Marketing Authorisation - Legal basis - Practical aspects linked to module 1 - Nicolas Nyssen (FAMHP) & Machteld Verbruggen (FAMHP)
-
-
17:15 - 17:30
-
Closing remarks - Marc Benijts (Healixia)
-